Novel devices, drugs driving expansion in glaucoma marketFebruary 11th 2022
The introduction of new devices is possibly the single most influential factor currently driving the glaucoma market, said Kristen Harmon Ingenito, MBA, in her presentation during the New Horizons Forum at the 2022 Glaucoma 360.
Glaucoma 360: Science fiction or science fact in eye careFebruary 11th 2022
Ranya Habash, MD, medical director of Technology Innovation, assistant professor of Clinical Ophthalmology at Bascom Palmer Eye Institute, University of Miami in Miami, Florida, offers a preview of her New Horizons keynote speech on "The future of eye care: science fiction to science fact."
The latest innovations in ophthalmic care for glaucoma patientsFebruary 11th 2022
Ora Chief Medical Officer Gustavo De Moraes, MD, PhD, MPH, speak with Ophthalmology Times®' Sheryl Stevenson to discuss some of the cutting-edge advancements in therapies and diagnostics for the treatment of glaucoma patients.
Glaucoma 360: Annual event celebrates research, industry, philanthropyFebruary 11th 2022
Glaucoma 360's co-founders and co-chairs Adrienne L. Graves, PhD, and Andrew G. Iwach, MD, speak with Ophthalmology Times®' Sheryl Stevenson on what attendees can expect from this year's annual meeting.
CEBF virtual symposium showcases vision research from three Northeast Ohio institutionsFebruary 2nd 2022
Cleveland Eye Bank Foundation (CEBF) will feature nine researchers from three eye institutions on February 15, from 3 to 5 pm Eastern, for its second annual virtual vision research symposium.
Angiogenesis 2022: Retina specialists are excited for these 10 scientific sessionsJanuary 25th 2022
This Bascom Palmer Eye Institute 2-day virtual scientific program promises a distinguished international faculty who will share the latest developments in imaging, translational research, and clinical trials as well as the impact these advances will have on clinical ophthalmology.
Study finds progressive declines in vision in aging patients with diffractive multifocal IOLsJanuary 14th 2022
According to investigators, patients implanted with diffractive multifocal IOLs had notable declines in the corrected distance visual acuity, distance corrected near VA, and near area of focus with aging
Alcon completes acquisition of Ivantis Inc.January 10th 2022
The acquisition brings the Hydrus Microstent into Alcon’s global surgical portfolio. The company will leverage its global footprint and leadership in ophthalmology to drive future growth, bringing the device to more patients worldwide.
Streamlining the preoperative cataract surgery protocol while maintaining high care standardsDecember 23rd 2021
A virtual, risk-based approach to preoperative medical evaluations for cataract surgery may be associated with safe and efficient outcomes, according to study investigators.